Cross-clade protection against HPAI H5N1 influenza virus challenge in BALB/c mice intranasally administered adjuvant-combined influenza vaccine

Veterinary Microbiology

Volumn 146, Issue 1-2, 2010, Pages 17-23

  Yang, Penghui ^a   Tang, Chong ^a   Luo, Deyan ^a   Zhan, Zhongpeng ^a   Xing, Li ^a   Duan, Yueqiang ^a   Jia, Weihong ^a   Peng, Daxin ^b   Liu, Xiufan ^b   Wang, Xiliang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

Adjuvant; H5N1 influenza vaccine; Mucosal immunity

Indexed keywords

CHOLERA TOXIN; CHOLERA TOXIN B SUBUNIT; INFLUENZA VACCINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; VIRUS REPLICATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; VACCINES, SYNTHETIC; VIRAL LOAD;

ANIMALIA; AVES; MUS; ORTHOMYXOVIRIDAE;

EID: 78049278349     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2010.03.024     Document Type: Article

References (28)

1. Asanuma, H., Fujihashi, K., Miyakoshi, T., Yoshikawa, T., Fujita-Yamaguchi, Y., Kojima, N., Nakata, M., Suzuki, Y., Tamura, S., Kurata, T., Sata, T., 2007. Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine. PMID: 17716790 [PubMed - indexed for MEDLINE].
2. Clark T.W., Pareek M., Hoschler K., Dillon H., Nicholson K.G., Groth N., Stephenson I. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N. Engl. J. Med. 2009, 361(December(25)):2424-2435. Epub 2009 September 10.
3. De Filette, M., Ramne, A., Birkett, A., Lycke, N., Löwenadler, B., Min Jou, W., Saelens, X., Fiers, W., 2006. The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection. Vaccine 24 (January(5)), 544-551, Epub August 31. PMID: 16169634 [PubMed - indexed for MEDLINE].
4. Démoulins T., Baron M.L., Kettaf N., Abdallah A., Sharif-Askari E., Sékaly R.P. Poly(I:C) induced immune response in lymphoid tissues involves three sequential waves of type I IFN expression. Virology 2009, 386(April(2)):225-236. Epub 2009 February 20. PMID: 19232663 [PubMed - indexed for MEDLINE].
5. Ehrlich H.J., Müller M., Oh H.M., Tambyah P.A., Joukhadar C., Montomoli E., Fisher D., Berezuk G., Fritsch S., Löw-Baselli A., Vartian N., Bobrovsky R., Pavlov B.G.A., Pöllabauer E.M., Kistner O., Barrett P.N. Baxter H5N1 Pandemic Influenza Vaccine Clinical Study Team. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N. Engl. J. Med. 2008, 358:2573-2584.
6. El Sahly H.M., Keitel W.A. Pandemic H5N1 influenza vaccine development: an update. Expert Rev. Vacc. 2008, 7(March(2)):241-247. (review).
7. Fan S., Gao Y., Shinya K., Li C.K., Li Y., Shi J., Jiang Y., Suo Y., Tong T., Zhong G., Song J., Zhang Y., Tian G., Guan Y., Xu X.N., Bu Z., Kawaoka Y., Chen H. Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates. PLoS Pathog. 2009, 5(May(5)):e1000409. Epub 2009 May 1.
8. Forrest H.L., Khalenkov A.M., Govorkova E.A., Kim J.K., Del Giudice G., Webster R.G. Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets. Vaccine 2009, 27(June(31)):4187-4195. Epub 2009 May 9.
9. + T cell response that predicts long-term persistence of protective antibody levels. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(March(10)):3877-3882. February 23. PMID: 19237568 [PubMed - indexed for MEDLINE].
10. Ichinohe T., Kawaguchi A., Tamura S., Takahashi H., Sawa H., Ninomiya A., Imai M., Itamura S., Odagiri T., Tashiro M., Chiba J., Sata T., Kurata T., Hasegawa H. Intranasal immunization with H5N1 vaccine plus polyI:polyC12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Microb. Infect. 2007, 9(September(11)):1333-1340. Epub 2007 July 1. PMID: 17890128 [PubMed - indexed for MEDLINE].
11. Ichinohe T., Watanabe I., Ito S., Fujii H., Moriyama M., Tamura S., Takahashi H., Sawa H., Chiba J., Kurata T., Sata T., Hasegawa H. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. J. Virol. 2005, 79(March(5)):2910-2919. PMID: 15709010 [PubMed - indexed for MEDLINE].
12. Isaka M., Zhao Y., Nobusawa E., Nakajima S., Nakajima K., Yasuda Y., Matsui H., Hasegawa T., Maeyama J., Morokuma K., Ohkuma K., Tochikubo K. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice. Microbiol. Immunol. 2008, 52(February(2)):55-63. PMID: 18380802 [PubMed - indexed for MEDLINE].
13. Leroux-Roels I., Leroux-Roels G. Current status and progress of prepandemic and pandemic influenza vaccine development. Expert Rev. Vacc. 2009, 8(April(4)):401-423. PMID: 19348557 [PubMed - indexed for MEDLINE].
14. Leroux-Roels I., Borkowski A., Vanwolleghem T., Dramé M., Clement F., Hons E., Devaster J.M., Leroux-Roels G. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 2007, 370(August(9587)):580-589. PMID: 17707753 [PubMed - indexed for MEDLINE].
15. Neumann G., Noda T., Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009, 459(June(7249)):931-939. PMID: 19525932 [PubMed - in process].
16. O'Neill E., Donis R.O. Generation and characterization of candidate vaccine viruses for prepandemic influenza vaccines. Curr. Top. Microbiol. Immunol. 2009, 333:83-108.
17. Patel G.B., Zhou H., Ponce A., Chen W. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines. Vaccine 2007, 25(December(51)):8622-8636. Epub 2007 October 5. PMID: 17959279 [PubMed - indexed for MEDLINE].
18. Prabakaran M., Velumani S., He F., Karuppannan A.K., Geng G.Y., Yin L.K., Kwang J. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Virology 2008, 380(October(2)):412-420. Epub September 10. PMID: 18786689 [PubMed - indexed for MEDLINE].
19. Russell M.W., Martin M.H., Wu H.Y., Hollingshead S.K., Moldoveanu Z., Mestecky J. Strategies of immunization against mucosal infections. Vaccine 2000, 19(December(Suppl. 1)):S122-S127. (review) PMID: 11163475 [PubMed - indexed for MEDLINE].
20. Schultze V., D'Agosto V., Wack A., Novicki D., Zorn J., Hennig R. Safety of MF59 adjuvant. Vaccine 2008, 26(June(26)):3209-3222. (review) Epub 2008 April 21. PMID: 18462843 [PubMed - indexed for MEDLINE].
21. Smith G.J., Vijaykrishna D., Bahl J., Lycett S.J., Worobey M., Pybus O.G., Ma S.K., Cheung C.L., Raghwani J., Bhatt S., Peiris J.S., Guan Y., Rambaut A. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009, 459(June(7250)):1122-1125. PMID: 19516283 [PubMed - indexed for MEDLINE].
22. Stephenson I., Nicholson K.G., Hoschler K., Zambon M.C., Hancock K., DeVos J., Katz J.M., Praus M., Banzhoff A. Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. N. Engl. J. Med. 2008, 359(October(15)):1631-1633. PMID: 18843132 [PubMed - indexed for MEDLINE].
23. Takada A., Matsushita S., Ninomiya A., Kawaoka Y., Kida H. Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 2003, 21(July(23)):3212-3218.
24. Tang Y., Wu P., Peng D., Liu X., et al. Characterization of the complete genome of four influenza viruses H5N1 isolated from mallard and ostrich. Chin. J. Zoo. 2008, 24(11):1006-1013.
25. Vogel F.R., Caillet C., Kusters I.C., Haensler J. Emulsion-based adjuvants for influenza vaccines. Expert Rev. Vacc. 2009, 8(April(4)):483-492. PMID: 19348563 [PubMed - indexed for MEDLINE].
26. Wack A., Baudner B.C., Hilbert A.K., Manini I., Nuti S., Tavarini S., Scheffczik H., Ugozzoli M., Singh M., Kazzaz J., Montomoli E., Del Giudice G., Rappuoli R., O'Hagan D.T. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice. Vaccine 2008, 26(January(4)):552-561. Epub 2007 December 7. PMID: 18162266 [PubMed - indexed for MEDLINE].
27. Webster R.G., Kawaoka Y., Taylor J., Weinberg R., Paoletti E. Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 1991, 9(May(5)):303-308. PMID: 1651609 [PubMed - indexed for MEDLINE].
28. Zanvit P., Havlícková M., Tácner J., Novotná O., Jirkovská M., Cechová D., Julák J., Sterzl I., Prokesová L. Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant. Immunol. Lett. 2008, 115(January(2)):144-152. Epub 2007 November 29. PMID: 18160106 [PubMed - indexed for MEDLINE].